Page last updated: 2024-08-25

ranimustine and Hodgkin Disease

ranimustine has been researched along with Hodgkin Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Harigae, H; Hirokawa, M; Ishida, Y; Ishizawa, K; Ito, J; Kameoka, Y; Kato, Y; Murai, K; Noji, H; Sasaki, O; Sawada, K; Shichishima, T; Tajima, K; Takahashi, N	1

Trials

1 trial(s) available for ranimustine and Hodgkin Disease

Article	Year
Safety and feasibility of high-dose ranimustine (MCNU), carboplatin, etoposide, and cyclophosphamide (MCVC) therapy followed by autologous stem cell transplantation for malignant lymphoma. International journal of hematology, 2012, Volume: 96, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nitrosourea Compounds; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous	2012

Article

Year

Safety and feasibility of high-dose ranimustine (MCNU), carboplatin, etoposide, and cyclophosphamide (MCVC) therapy followed by autologous stem cell transplantation for malignant lymphoma.

International journal of hematology, 2012, Volume: 96, Issue:5

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nitrosourea Compounds; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous

2012